Description

Top Quality 5-CL-ADB-A  For Sale

What is  5-CL-ADB-A?

5-CL-ADB-A is an indazole synthetic cannabinoids which is a designer drug of a amylened 5f-adb derivative where methyl ester is replace with an amylene. 5-CL-ADB-A  For Sale.

However it  is only for research chemical purpose, and  also should never be take by humans, or use for any kind of chemical in vivo research. In addition it is sell  for purposes  in vitro experimentation or for sample calibration .

SUBSTANCE IDENTIFICATION, 5-CL-ADB-A  For Sale

5-CL-ADB-A is an analoge of a amylened 5F-ADB derivative in which the methyl ester has been replaced with a amylene. 5-CL-ADB-A has formal name: methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate. Molecular weight: 357.45

EFFECT AND DOSAGE OF 5-CL-ADB-A

When smoke, 5-CL-ADB-A produces cannabimimetic effects like THC. Doses needed to produce these effects are much lower than for THC.

TOXICOLOGY OF 5-CL-ADB-A

There are no published pre-clinical safety data available concerning the toxicity, reproductive impact and carcinogenic/mutagenic potential of 5-CL-ADB-A.

5-cl-adb-a behave in similar ways since they are analogues with similar structures.

 Indeed, the study found that all such synthetic cannabinoids are agonists that act on both CB1 and CB2 cannabinoid receptors in the body’s endocannabinoid system.

This suggests they have a cannabimimetic effect. Thus, can be potentially more potent than cannabis’s psychoactive compound THC. THC works by acting on these same cannabinoid receptors.

There is no one sure way to identify the abuse of research chemicals and designer drugs. Because these drugs are designed so that they, in some cases, mimic existing drugs of all types and, in other cases, behave independently of any original drug, signs and symptoms of use and abuse of these drugs vary widely.

However, one way to help identify the abuse of research chemicals is to become familiar with the signs and symptoms of the drugs they are closely related to as well as with the known designer drugs on the market as the information becomes available.